Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases

Alberto Ruano-Ravina, María Torres-Durán, Karl T. Kelsey, Isaura Parente-Lamelas, Virginia Leiro-Fernández, Ihab Abdulkader, José Abal-Arca, Carmen Montero-Martínez, Iria Vidal-García, Margarita Amenedo, Olalla Castro-Añón, Antonio Golpe-Gómez, Javier González-Barcala, Cristina Martínez, Rosirys Guzmán-Taveras, Mariano Provencio, María José Mejuto-Martí, Alberto Fernández-Villar and Juan Miguel Barros-Dios

Source: Eur Respir J 2016; 48: 1462-1470
Journal Issue: November

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alberto Ruano-Ravina, María Torres-Durán, Karl T. Kelsey, Isaura Parente-Lamelas, Virginia Leiro-Fernández, Ihab Abdulkader, José Abal-Arca, Carmen Montero-Martínez, Iria Vidal-García, Margarita Amenedo, Olalla Castro-Añón, Antonio Golpe-Gómez, Javier González-Barcala, Cristina Martínez, Rosirys Guzmán-Taveras, Mariano Provencio, María José Mejuto-Martí, Alberto Fernández-Villar and Juan Miguel Barros-Dios. Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases. Eur Respir J 2016; 48: 1462-1470

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is residential radon associated with mutations in drivers genes in never smokers lung cancer cases? The case of EGFR and ALK
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort
Source: Eur Respir J 2012; 40: 177-184
Year: 2012



Asbestos-related lung cancers are rarely associated with ALK, ROS1 and RET rearrangements
Source: Eur Respir J, 51 (3) 1702605; 10.1183/13993003.02605-2017
Year: 2018



K-RAS oncogenic mutations in patients with nonsmall cell lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


Study of NF2 and P16/CDKN2A genes in lung cancer in patients occupationally exposed to asbestos
Source: Eur Respir J 2004; 24: Suppl. 48, 146s
Year: 2004

Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients
Source: Eur Respir Rev 2014; 23: 390-392
Year: 2014


Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Mutation of TP53 and KRAS, and loss of p16ink4a and p14arf expression in lung cancers in relation to tobacco smoke
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005

Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013


Clinical relevance of p53 and K-ras mutations in nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001

Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 18s
Year: 2001

Germline mutations in young never-smokers with lung adenocarcinoma
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

Association between lung cancer somatic mutations and occupational exposure in never-smokers
Source: Eur Respir J, 50 (4) 1700716; 10.1183/13993003.00716-2017
Year: 2017



Model for predicting EGFR mutation status in lung cancer
Source: Breathe, 15 (4) 340; 10.1183/20734735.0250-2019
Year: 2019



Prognostic  value of  EGFR  genotype  in  EGFR-mutant  non-small  cell lung  cancer
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


p53 gene mutations in lung cancer in Korean
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
Source: Eur Respir J 2011; 37: 624-631
Year: 2011



Croatian Caucasians with lung adenocarcinoma harbouring EGFR mutations with and without brain metastasis
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

The association between residential radon concentration and lung cancer
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011